Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Crotalinae snake venom toxins are a complex mixture of proteins and enzymes produced by snakes in the subfamily Crotalinae (pit vipers), such as rattlesnakes, cottonmouths, and copperheads. These mixtures are not a single molecular target, but rather contain diverse protein classes including neurotoxins, myotoxins, cytotoxins, hemotoxins, and enzymes like metalloproteinases and phospholipase A2, each acting via different pathological mechanisms including membrane disruption, tissue necrosis, coagulopathy, and modulation of ion channels. Rather than being a therapeutic drug target, these venoms are the cause of envenomation, and antivenoms (such as CroFab) are used to bind and neutralize the toxins, reducing morbidity and mortality. The entry "Venom toxins from Crotalinae snakes" does not refer to a specific drug target, but instead to a heterogenous mixture of toxins, so it should not be considered a defined molecular target for structured pharmaceutical targeting[1][2][3][5][6].
Neutralization and clearance of venom toxins by antigen-binding fragments (Fab) of antibodies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crotalinae snake venom toxin.